Published in Women's Health Weekly, May 2nd, 2002
The primary purpose of this 14 patient, pharmacokinectic study is to determine serum testosterone and estrogen levels in women following multidose topical administration of Estrasorb and Androsorb when given simultaneously.
Dr. Craig Wright, Novavax's chief scientific officer, stated, "This is an important clinical trial for Novavax in that it is the first time we are administering...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly